Construction of a Novel Doxorubicin Nanomedicine Using Bindarit as a Carrier: A Multiscale Computer Simulation-Assisted Design-Based Study
Nanomedicines typically use polymeric materials or liposomes as carriers. This provides targeting advantages but may lead to a series of defects, such as low drug loading, high risk in terms of safety, and high production costs. Herein, we report a computer simulation-assisted designing method for t...
Guardado en:
Autores principales: | Anjie Shi, Ling Long, Zhibin Liu, Yao Liu, Qingjia Gong, Chengyuan Zhang, Hongfeng Yuan, Xing Zhou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f504f20bd16c4554a47283f2359b5457 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin
por: Han Y, et al.
Publicado: (2014) -
The anti-inflammatory agent bindarit acts as a modulator of fatty acid-binding protein 4 in human monocytic cells
por: Sergio Oddi, et al.
Publicado: (2019) -
A facile doxorubicin-dichloroacetate conjugate nanomedicine with high drug loading for safe drug delivery
por: Yang CL, et al.
Publicado: (2018) -
In vitro evaluation of anticancer nanomedicines based on doxorubicin and amphiphilic Y-shaped copolymers
por: Li D, et al.
Publicado: (2012) -
Advances of Nanomedicine in Radiotherapy
por: Wei Liu, et al.
Publicado: (2021)